Breast Metastasis From a Melanoma

REFERENCES

1. ↵
   1. Kurul S,
   2. Taş F,
   3. Büyükbabani N,
   4. Mudun A,
   5. Baykal C,
   6. Camlica H

   (4, 2005) Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature. Jpn J Clin Oncol 35(4):202–206, pmid:15845569.

   OpenUrlCrossRefPubMedWeb of Science
2. 1. Kurul S

   (8, 2000) Diffuse microscopic intransit metastases from malignant melanoma of the breast. Plast Reconstr Surg 106(2):513–514, pmid:10946962.

   OpenUrlPubMed
3. ↵
   1. Bassi F,
   2. Gatti G,
   3. Mauri E,
   4. Ballardini B,
   5. De Pas T,
   6. Luini A

   (12, 2004) Breast metastases from cutaneous malignant melanoma. Breast 13(6):533–535, pmid:15563866.

   OpenUrlPubMed
4. ↵
   1. Bahat G,
   2. Colak Y,
   3. Saka B,
   4. Karan MA,
   5. Buyukbabani N

   (2009;) Melanoma metastasis to the breast: a diagnostic pitfall. Cancer Detect Prev 32((5-6)):458–461, pmid:19588546.

   OpenUrlCrossRefPubMed
5. ↵
   1. Cangiarella J,
   2. Symmans WF,
   3. Cohen JM,
   4. Goldenberg A,
   5. Shapiro RL,
   6. Waisman J

   (6 25, 1998) Malignant melanoma metastatic to the breast: a report of seven cases diagnosed by fine-needle aspiration cytology. Cancer 84(3):160–162, pmid:9678730.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Ravdel L,
   2. Robinson WA,
   3. Lewis K,
   4. Gonzalez R

   (8 1, 2006) Metastatic melanoma in the breast: a report of 27 cases. J Surg Oncol 94(2):101–104, pmid:16847918.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Arora R,
   2. Robinson WA

   (5, 1992) Breast metastases from malignant melanoma. J Surg Oncol 50(1):27–29, pmid:1573892.

   OpenUrlPubMedWeb of Science
8. ↵
   1. Nalbant OA,
   2. Vural S,
   3. Keles MC,
   4. Nalbant E,
   5. Kandiloglu AR

   (2011;) Metastatic malignant melanoma of the breast: a case report. J Breast Health 7(1):36–39.

   OpenUrl
9. ↵
   1. Majeski J

   (11, 1999) Bilateral breast masses as initial presentation of widely metastatic melanoma. J Surg Oncol 72(3):175–177, pmid:10562365.

   OpenUrlPubMed
10. ↵
    1. Vergier B,
    2. Trojani M,
    3. de Mascarel I,
    4. Coindre JM,
    5. Le Treut A

    (10, 1991) Metastases to the breast: differential diagnosis from primary breast carcinoma. J Surg Oncol 48(2):112–116, pmid:1921396.

    OpenUrlPubMedWeb of Science
11. ↵
    1. Loffeld A,
    2. Marsden JR

    (6, 2005) Management of melanoma metastasis to the breast: case series and review of the literature. Br J Dermatol 152(6):1206–1210, pmid:15948983.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Toombs BD,
    2. Kalisher L

    (10, 1977) Metastatic disease to the breast: clinical, pathologic, and radiographic features. AJR Am J Roentgenol 129(4):673–676, pmid:409241.

    OpenUrlPubMedWeb of Science
13. ↵
    1. Charfi S,
    2. Makni SK,
    3. Khanfir A,
    4. et al.

    (6, 2008) [Breast metastasis: anatomoclinical study of six cases]. J Gynecol Obstet Biol Reprod (Paris) 37(4):346–352, pmid:18406542, Epub 2008 Apr 11. French.

    OpenUrlPubMed
14. ↵
    1. Janni W,
    2. Rack B,
    3. Sommer H,
    4. et al.

    (9, 2003) Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases. J Cancer Res Clin Oncol 129(9):503–510, pmid:12884027, Epub 2003 Jul 18.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Abrams HL,
    2. Spiro R,
    3. Goldstein N

    (1, 1950) Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3(1):74–85, pmid:15405683.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Marsden JR,
    2. Newton-Bishop JA,
    3. Burrows L,
    4. et al.,
    5. British Association of Dermatologists Clinical Standards Unit

    (8, 2010) Revised U.K. guidelines for the management of cutaneous melanoma 2010 Br J Dermatol 163(2):238–256, Epub 2010 Jul 1.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Atallah E,
    2. Flaherty L

    (5, 2005) Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 6(3):185–193, pmid:15869730.

    OpenUrlCrossRefPubMed
18. ↵
    1. Chapman PB,
    2. Hauschild A,
    3. Robert C,
    4. et al.

    (6 30, 2011) BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364(26):2507–2516, pmid:21639808, Epub 2011 Jun 5.

    OpenUrlCrossRefPubMedWeb of Science